IOCAS-IR

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                            
已选(0)清除 条数/页:   排序方式:
Cu(II)-Catalyzed Oxidative Trifluoromethylation of Indoles with KF as the Base 期刊论文
CATALYSTS, 2019, 卷号: 9, 期号: 3, 页码: 14
作者:  Shi, Xiaolin;  Li, Xiaowei;  Ma, Lina;  Shi, Dayong
Adobe PDF(1208Kb)  |  收藏  |  浏览/下载:347/0  |  提交时间:2019/08/28
Cu(II) catalyst  Langlois reagent  trifluoromethylation  indole  radical reaction  
Iron-catalyzed alkynylation of tertiary aliphatic amines with 1-iodoalkynes to synthesize propargylamines 期刊论文
ORGANIC CHEMISTRY FRONTIERS, 2018, 卷号: 5, 期号: 24, 页码: 3515-3519
作者:  Ma, Lina;  Shi, Xiaolin;  Li, Xiaowei;  Shi, Dayong
Adobe PDF(601Kb)  |  收藏  |  浏览/下载:250/0  |  提交时间:2019/05/15
Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 28, 期号: 12, 页码: 2131-2135
作者:  Li, Ning;  Wang, Li-Jun;  Jiang, Bo;  Guo, Shu-Ju;  Li, Xiang-Qian;  Chen, Xue-Chun;  Luo, Jiao;  Li, Chao;  Wang, Yi;  Shi, Da-Yong
Adobe PDF(824Kb)  |  收藏  |  浏览/下载:313/0  |  提交时间:2019/08/21
Pyrimidinedionederivatives  DPP-4 inhibitor  Molecular hybrid  SARs  Type 2 diabetes  
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 151, 页码: 145-157
作者:  Li, Ning;  Wang, Li-Jun;  Jiang, Bo;  Li, Xiang-qian;  Guo, Chuan-long;  Guo, Shu-ju;  Shi, Da-Yong
Adobe PDF(1523Kb)  |  收藏  |  浏览/下载:317/0  |  提交时间:2019/08/21
DPP-4  Inhibitors  Analogs  Physico-chemical properties  SARs  Type 2 diabetes  
Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation 期刊论文
MARINE DRUGS, 2017, 卷号: 15, 期号: 11, 页码: 18
作者:  Wang, Li-Jun;  Guo, Chuan-Long;  Li, Xiang-Qian;  Wang, Shuai-Yu;  Jiang, Bo;  Zhao, Yue;  Luo, Jiao;  Xu, Kuo;  Liu, Hua;  Guo, Shu-Ju;  Wu, Ning;  Shi, Da-Yong
收藏  |  浏览/下载:331/0  |  提交时间:2019/07/15
bromophenol hybrids  anticancer  structure-activity relationships  ROS  apoptotic pathway